A Trial of JX-594 in Refractory Colorectal Carcinoma
Ontology highlight
ABSTRACT: The purpose of this study is to:
* determine the maximally-tolerated dose (MTD) and/or maximum-feasible dose (MFD) of JX-594 administered by biweekly intravenous (IV) infusion.
* determine the safety of JX-594(TK- GM-CSF+ Wyeth strain vaccinia) administered by biweekly IV infusion.
DISEASE(S): Colorectal Carcinoma,Carcinoma,Colorectal Neoplasms
PROVIDER: 2115509 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA